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monocyte populations in cattle peripheral blood
identifies a subset with high endocytic and
allogeneic T-cell stimulatory capacity
Yolanda Corripio-Miyar1* , Jayne Hope1, Colin J McInnes2, Sean R Wattegedera2, Kirsty Jensen1, Yvonne Pang2,
Gary Entrican1,2 and Elizabeth J Glass1Abstract
Circulating monocytes in several mammalian species can be subdivided into functionally distinct subpopulations
based on differential expression of surface molecules. We confirm that bovine monocytes express CD172a and MHC
class II with two distinct populations of CD14+CD16low/-CD163+ and CD14−CD16++CD163low- cells, and a more diffuse
population of CD14+CD16+CD163+ cells. In contrast, ovine monocytes consisted of only a major CD14+CD16+ subset
and a very low percentage of CD14−CD16++cells. The bovine subsets expressed similar levels of CD80, CD40 and
CD11c molecules and mRNA encoding CD115. However, further mRNA analyses revealed that the CD14−CD16++
monocytes were CX3CR1highCCR2low whereas the major CD14+ subset was CX3CR1lowCCR2high. The former were
positive for CD1b and had lower levels of CD11b and CD86 than the CD14+ monocytes. The more diffuse CD14+
CD16+ population generally expressed intermediate levels of these molecules. All three populations responded to
stimulation with phenol-extracted lipopolysaccharide (LPS) by producing interleukin (IL)-1β, with the CD16++ subset
expressing higher levels of IL-12 and lower levels of IL-10. The CD14−CD16++ cells were more endocytic and induced
greater allogeneic T cell responses compared to the other monocyte populations. Taken together the data show both
similarities and differences between the classical, intermediate and non-classical definitions of monocytes as described
for other mammalian species, with additional potential subpopulations. Further functional analyses of these monocyte
populations may help explain inter-animal and inter-species variations to infection, inflammation and vaccination in
ruminant livestock.Introduction
The innate immune system is the first line of host
defense against pathogens, playing an important role
during the early phase of infection. Myeloid cells are
among the key mediators of the innate immune system
and consist of heterogeneous populations with overlap-
ping relationships and function between monocytes,
macrophages and dendritic cells (DC) [1-3]. These pop-
ulations differ phenotypically and functionally from each
other based on their tissue location and previous* Correspondence: Yolanda.Corripio-Miyar@moredun.ac.uk
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the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zeenvironmental history [1-5]. Myeloid cells link the innate
immune response to the ensuing adaptive immune re-
sponse as antigen presenting cells. However, what is less
clear is the relative contribution of different subsets of
myeloid cells, namely monocytes, macrophages and DC
in vivo to T cell priming, modulating and directing the
quality of the elicited immune response or their precise
role in inducing pathology or protection [2,6]. It is likely
that different myeloid subsets are important for control-
ling different pathogens. Consequently, one way to im-
prove the efficacy of vaccines is to identify and target
the myeloid subsets that are important for driving im-
mune responses in appropriate directions.
Historically, most research into myeloid cells has con-
centrated on cell subsets derived from mouse tissue and,s article is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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including cells that have been differentiated in vitro. It is
not entirely clear how these subsets in different species
relate to each other, or how relevant in vitro derived
myeloid cells are to the cells observed in specific tissue
locations in vivo. However in general, the consensus is
that in humans and mice, monocytes can be divided into
two distinct subpopulations together with a third less
well defined intermediate subpopulation [4]. These sub-
populations appear to be phenotypically and functionally
similar between the two species and are distinguished on
the basis of CD14 and CD16 (FcγRII) expression in
humans and Ly6C and CD43 in mice [7,8]. The major
human monocyte population is referred to as “classical”
and is CD14++CD16− (Ly6C++CD43+ in the mouse) and
the minor is a more mature human population referred to
as “non-classical” which is CD14+CD16++ (Ly6C+CD43++
in the mouse). The latter represents around 10% of the
total monocyte population [9]. The intermediate popu-
lation likely represents gradual development from clas-
sical to non-classical monocytes, thus delineating this
population by the expression levels for these markers
can be difficult and it has been recommended that
threshold expression levels should be adopted with
reference to isotype controls [4]. However some au-
thors consider that the intermediate monocytes and the
non-classical CD14+CD16++ monocytes form a single
population, even though phenotypic and gene expres-
sion differences between these populations have been
reported [2]. Although these different monocyte popu-
lations show distinct phenotype and function [2–4],
there is still controversy over the precise role of each of
these subsets in inflammatory conditions [4,10]. The
evidence derived mainly from mouse studies suggests
that the classical monocyte population responds to
cytokine and chemokine signals by entering sites of
infection and differentiating into macrophages and den-
dritic cells, thus contributing to inflammation and reso-
lution of the infection [2]. These activities are reflected in
human classical monocyte responses to TLR ligands
which result in pro-inflammatory cytokine up-regulation,
accompanied by release of interleukin (IL)-10, although
some studies suggest the intermediate monocyte popula-
tion is the major IL-10 producing subset [11]. In contrast
the non-classical population appears to be mainly involved
in patrolling the endothelium of the blood vessels,
expressing very little IL-10 and with high levels of the
pro-inflammatory cytokine tumour necrosis factor-alpha
(TNF-α) [12,13].
It is becoming clearer that rodents are not always the
most suitable models for human immunological studies
as their immune repertoire and physiology is distinct
[14–16]. Indeed in comparing artiodactyla, primates and
rodents in terms of evolution of codon usage, rodentsare revealed to be an outgroup [17] and their immune
responses would also suggest closer relationships exist
between these larger mammals compared to rodents
[14,18–20]. Nonetheless, it is also important to note that
livestock species are affected by overlapping, zoonotic
and distinct pathogens resulting in differential evolutionary
selective pressure on host immune genes and pathways
[21–23]. Indeed, although porcine monocyte subsets have
similar characteristics to human classical and intermediate
populations, there does not appear to be a non-classical
equivalent [18]. Thus a broader exploration of the range of
species differences in immune cells and mechanisms has
the potential to shed light on our understanding of the di-
versity of innate immunity and evolution of host-pathogen
interactions as livestock species offer the opportunity to
study host responses to pathogens within the natural host
[19,24–26]. Together with the capability to access different
tissue compartments, these larger mammalian species pro-
vide alternative models to explore monocyte/macrophage
relationships in health and disease.
Current knowledge of myeloid cell lineages and func-
tional specialisation in ruminants is limited. CD16 has
previously been reported to be expressed on natural
killer (NK) cells in cattle [27] and sheep [28], while
CD14 is characteristically expressed on monocytes/macro-
phages in ruminants [29,30]. A recent report by Hussen
et al. [31] has suggested that, in contrast to findings in
humans and mice, a bovine non-classical CD14+CD16+
population exists in peripheral blood monocytes and is
relatively non-inflammatory.
Here, we focus on extending the phenotypic and func-
tional characterisation of myeloid cell populations in the
peripheral blood of cattle as a basis for exploring their
relationships to myeloid cells trafficking into sites of infec-
tion and their role in pathogen and vaccine responses.
Materials and methods
Animals
Healthy Holstein-Friesian cattle were maintained at The
Roslin Institute (RI), UK. In some experiments calves of
defined MHC class I haplotype [32,33] were used. All
cattle were animals under 2 years of age and kept off
pasture. Healthy Texel-Greyface sheep were derived
from the breeding stock at the Moredun Research Insti-
tute (MRI) and kept off pasture. All experiments were
approved by Ethics Committees at RI and MRI and were
performed to Home Office Guidelines under Project
Licences (PPL 60/4394 and PPL 60/3854 respectively).
Flow cytometric analysis
Single or multiple colour flow cytometric analyses were
carried out on peripheral blood mononuclear cells
(PBMC) from both sheep and cattle. Blood was collected
aseptically into blood bags containing 70 mL of citrate
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(Sarstedt, Germany) for cattle or in sodium heparin
vacutainers (Becton Dickinson, Oxford, UK) for sheep.
PBMC were separated by density gradient centrifuga-
tion onto Lymphoprep (Axis-Shield, Scotland, UK) for
sheep, washed three times with phosphate buffered sa-
line (PBS) and re-suspended at 2 × 107 cells/mL in PBS
supplemented with 0.5% foetal bovine serum (FBS,
from Brazil supplied by Gibco, Life Technologies,
USA) ready for staining. Flow cytometry was carried
out using monoclonal antibodies (mAb) to the molecules
detailed in Table 1 on 106 cells per antibody combination
at pre-optimised concentrations. When primary mAbs
were unconjugated, isotype-specific secondary mAb con-
jugated to phycoerythrin (PE) (Invitrogen, Life Technolo-
gies, USA) was used. Finally, cells were resuspended in the
dead cell stain Sytox Blue (Invitrogen, Life Technologies,
USA) prior to analysis in flow cytometer. Dead cell and
doublet cell discrimination (Figure 1A and B) was carried
out during analysis of the phenotyping and phagocytosis
studies, and Fluorescence Minus One (FMO) controls
were used in multiple colour flow cytometry (Figure 1C-Table 1 Antibodies list
Antigen Antibody nomenclature Isotype
CD1b CC14 IgG1
CD80 IL-A159 IgG1
CD86 IL-A190 IgG1
CD40 IL-A156 IgG1
MHCII-DR CC108 IgG1
CD11b CC94 IgG1
CD11c NAM4 IgG1
CD2 CC42 IgG1
CD3 MM1A IgG1
CD4 CC30 IgG2a
CD8α CC63 IgG2a
CD8β CC58 IgG1
CD21 CC21 IgG1
NKp46 GR13.1(EC1.1) IgG1
CD26 CC69 IgG1
CD172a CC149 IgG1
CD206 3.29B1.10 IgG1
TLR2 HuCaL AbD 16476.1
CD163 EDHu-1 IgG1
CD16 KD1 IgG2a
CD14 TUK4 IgG2a
IgG1 isotype control AV20 IgG1
IgG2a isotype control AV29 IgG2a
Monoclonal antibodies used for flow cytometric analysis. IAH, Institute for Animal H
of Edinburgh.E). Cells were initially stained for CD14, CD16, CD172a
and NKp46 to ascertain the major myeloid populations in
PBMC and to measure CD16 levels on NK cells enabling
exclusion from further analyses (Figure 1F-J). Phenotypes
were expressed as the geometric mean fluorescence
intensity (MFI) and/or % positivity and were collected
from six animals.
A minimum of 50 000 events were acquired using an
LSRFortessa™ cell analyzer (Becton Dickinson, Oxford,
UK) and analysed using FlowJo vX for Windows 7 or
FACSDiva v8.0 software.
Stimulation of purified myeloid cells with
lipopolysaccharide (LPS)
A total of 3 × 108 PBMC from six animals were labelled
with CD16 and CD14 antibodies and then purified into
three populations based on differential expression of
CD16 and CD14 (CD14+CD16+, CD14+CD16low/- and
CD14−CD16++) using a FACSAria™ III. After cell sorting,
the purities of each population were assessed and only
used if the purity was above 85% (Table 2). Cells were
washed with PBS and resuspended in RPMI-1640Conjugate Source
Nil IAH, AbD Serotec
Nil ILRI, AbD Serotec
Nil ILRI, AbD Serotec
Nil ILRI, AbD Serotec
Nil IAH, AbD Serotec
Nil IAH
Nil [44]
Nil IAH, AbD Serotec
Nil VMRD, Inc., Pullman, WA
R:PE IAH, AbD Serotec
R:PE IAH, AbD Serotec
R:PE IAH, AbD Serotec
Nil IAH, AbD Serotec
Nil Timothy Connelly (UoE), AbD Serotec
Nil IAH
Nil IAH
R:PE Beckman Coulter
Nil AbD Serotec
Nil AbD Serotec
FITC AbD Serotec
Alexa Fluor 647 AbD Serotec
Nil IAH, [35]
Nil IAH, [35]
ealth; ILRI, International Livestock Research Institute; UoE, University
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Figure 1 Gating strategies and myeloid population identification. The expression of CD16 and CD14 was determined by single and two
colour flow cytometry in freshly isolated bovine PBMC. The cells were gated to eliminate dead cells (A) and doublets (B). Threshold levels which
determined positivity for CD14 and CD16 were set with no antibody control (C, D and E) and FMO controls (F, G) were used to determine
quadrant position and fluorescence intensity for subsequent analysis. Cells above fluorescence of 400 for FITC (CD16) and above 300 for AF647
(CD14) were determined as positive for the respective molecules. In order to further define the CD16+ populations triple staining with CD14,
CD16 and NKp46 (I) or CD14, CD16 and CD172a (J) was carried out. Within PBMC gated as CD14−CD16+/++ (rectangular gate; H) the majority of
NKp46+ NK cells expressed CD16 at a fluorescence intensity of ~800-10 000 (I). The majority of cells which were CD172a negative (J) expressed
CD16 at fluorescence intensity ~800-10 000 corresponding with the NKp46+ population. A subpopulation of CD14− cells which were NKp46− and
CD172a+ were observed at fluorescence intensities ≥10 000 and were gated in further studies as a separate population for analysis. Data shown
are for one representative animal out of six.
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1% L-glutamine (mixed leukocyte culture media, MLC)
and 10% FBS. Each sorted population was then aliquoted
into two wells of a 12-well flat bottom plate (Corning
Costar, Sigma-Aldrich, UK) and stimulated for 18 h with
1 μg/mL of phenol-extracted LPS from E.coli 055:B5
(L2880; Sigma-Aldrich, UK) or incubated with PBS(control) at 37 °C with 5% CO2 in air. After the incubation
period, supernatants were obtained by centrifugation and
stored at −20 °C until assayed for cytokine production.
ELISA
Capture ELISAs were performed to examine the secre-
tion of selected cytokines. IL-1β and IL-6 ELISAs
Table 2 Details of the oligonucleotides used in the RT-qPCR analysis
Gene symbol Accession no. Orientation Sequence (5’-3’)
CCR2 NM_001194959 F GATGAAGAACCCACCACCAG
R CAAAGATGAAGACCAGCGAGTAG
CD14 NM_174008 F CGATTTCCGTTGTGTCTGC
R TACTGCTTCGGGTTGGTGT
CD16A NM_001077402 F TGTCTCGTCATTCTTTCTACCTTG
R ACTTTGCCATCCCTCCATTC
CD163 NM_001163413 F CTTCGGTCCCTTCACTCTTG
R CCAGCCTCAGTTCCTTGTCT
CD115 NM_001075403 F ACCTTGACATTGGAGCCTGA
R CGGAAGTCGGATTGTTGAGA
CX3CR1 NM_001102558 F TCACCAGAGAGAAAGAGAACGA
R GGAGCAGGAAGCCAAGAAA
CHAMP1 NM_001205506 F AGCAGTGACCAAGAGCAGGT
R TCATAGCACGACAGCAACAA
F and R denote forward and reverse oligonucleotides respectively.
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as per the manufacturer’s instructions. Antibodies for
IL-10 [34], IL-12 [35] and TNF-α [36] were obtained
from AbD Serotec, UK. All ELISAs were performed
as follows. All incubations were carried out at room
temperature and wash steps were performed 6 times
with 350 μl wash buffer (PBS + 0.05% Tween 20) using a
Skatron Skanwasher 300. Samples and reagents were ap-
plied in 100 μL volumes. High-binding capacity ELISA
plates (Maxisorp, Nunc, Denmark) were incubated with
coating antibodies overnight at room temperature and
then washed and blocked for 1 h. Following a further
washing step, cell supernatants and standards were added
in duplicate for 1 h. Titrated culture supernatants from
COS-7 cells transfected with IL-10, IL-12 or TNF-α were
used as standard preparations for the measurement of
these cytokines [37]. Subsequently plates were washed, de-
tection antibodies added for 1 h, followed by washing and
addition of Streptavidin-HRP for 45 min. After the final
washing step, TMB substrate was added and the reaction
was stopped by the addition of H2SO4. Absorbance values
were read at 450 nm and 550 nm (background). Since
different numbers of cells were obtained in the cell
sorts for each population (see Table 2), the OD values
were compared to the standard curves and values were
then normalised and expressed as the concentration
(picograms (pg) or biological units (BU)) relative to 106
cells.
Mixed leukocyte reaction
In order to determine the T cell stimulatory capability of
the cell populations of interest in the context of an allo-
geneic mixed leukocyte reaction (MLR), cells from two
animals with defined homozygous distinct MHC class Ihaplotypes (A14 and A10) were used [32,33]. PBMC
from both animals were isolated as described above and
re-suspended to a concentration of 106 cells/mL in MLC
with 10% FBS. Stimulator and responder cells were as
follows: responder cells were PBMC obtained from an
A10 calf. Stimulator allogeneic cells from an A14 (MHC
mismatched) calf were purified, irradiated (60Gy) myeloid
cells (CD14+CD16+, CD14+CD16low/- and CD14−CD16++).
Responder cells (105 per well) were incubated with 104,
103 or 102 stimulators (ratios of 10:1, 100:1 and 1000:1 re-
spectively) in quadruplicate in U-well microtitre plates in
a total volume of 200 μL. Controls consisted of responder
or non-irradiated stimulator cells in medium alone or with
5 μg/mL of ConA, and irradiated sorted cells alone. Cells
were incubated at 37 °C for 5 days. Proliferation was
measured by the incorporation of methyl-3H thymidine
(0.5 μCi per well; Amersham Biosciences UK Ltd, Chalfont
St. Giles, Buckinghamshire) for the final 18 h of culture
[38]. Data are presented as the corrected counts per minute
(ccpm) averaged over 3 min.
Tracer endocytosis
Freshly isolated PBMC from four animals were re-
suspended in PBS + 0.5% FBS at a concentration of 106
cells/mL. 100 μL of the cell suspension was incubated
with TexasRed-Dextran (Molecular Probes, Life Tech-
nologies, USA) or TexasRed-OVA (10 000 MW, Mo-
lecular Probes, Life Technologies, USA) at a final
concentration of 100 μg/mL for a period of 30 min at
37 °C or on ice in 96-well round-bottom plates. Cells
were then washed 3 times with cold PBS and then incu-
bated with fluorochrome-conjugated CD16 and CD14
mAbs. In order to take into consideration the non-
specific surface binding of both TexasRed-OVA and
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ice was compared to that of cells incubated at 37 °C.
Results for each population are therefore expressed as
the corrected MFI at 37 °C of cells gated as CD14+ or
CD14−CD16++.
RT-qPCR analysis
CD14−CD16++ and CD14+ populations were purified
from PBMC from four animals as follows. In order to
obtain a highly pure CD14−CD16++ population, PBMC
were incubated with FITC conjugated CD16 antibody
for 20 min at RT. After two washes, labelled cells were
incubated with Anti-FITC MicroBeads (Miltenyi Biotech,
Germany) for 30 min at 4 °C following manufacturer’s
instructions. Cells were then washed in MACS buffer and
loaded onto a LS separation column placed in the MACS
magnet. Cells labelled with the complex CD16-
FITC:MACS magnetic beads were eluted from the column
and washed twice in buffer. Cells enriched for CD16 were
then further sorted on the basis of the high level of CD16
expression on monocytes, using a FACSAria™ III, as
detailed above, resulting in a pure population of CD14
−CD16++ monocytes. A pure CD14+ population was ob-
tained from total PBMC using anti-human CD14 MACS
microbeads (Miltenyi Biotech, Germany) as detailed above
for the CD16 enrichment. In both cases purity was
assessed by flow cytometry to ascertain that purity was
higher than 85%. Purified populations were then lysed in
TRIzol® (Invitrogen, Life Technologies, US) and total RNA
was isolated following the manufacturer’s instructions.
Finally, RNA concentrations were quantified using a
Nanodrop Spectrophotometer (NanoDrop Technolo-
gies, Thermo Fisher Scientific, MA, USA) and quality
assessed with an Agilient 2100 Bioanalyzer RNA Kit
(Agilient Technologies, Santa Clara, California, USA).
First strand cDNA was reverse transcribed from
100 ng total RNA using oligo(dT) primer and GoScript
(Promega, Madison, Wisconsin, USA) according to the
manufacturer’s instructions. The qPCR was carried out
using the Brilliant III ultra-fast SYBR Green Mastermix
kit (Agilent Technologies, Santa Clara, California, USA).
Oligonucleotides were designed for each gene using Pri-
mer3 [39] and Netprimer (Biosoft International, Palo
Alto, California, USA) software (Table 2). Reactions were
carried out in 10 μL volumes containing: 6.5ul 1 × SYBR
Green Master mix with reference dye, 0.5 μL forward
and reverse primers at predetermined optimal concen-
trations and 2.5 μL cDNA diluted at 1:25 for all genes.
Amplification and detection of products was carried out
using a Mx3000P PCR machine (Stratagene, Agilient
Technologies, USA) with the following cycle profile: 95 °C
for 3 min followed by 50 cycles of 95 °C for 10 s and 60 °C
for 22 s. The detection of a single product was verified by
dissociation curve analysis. Each PCR experiment wascarried out in triplicate and contained several non-
template controls and a log10 dilution series of the repre-
sentative standard. The relative quantities of mRNA were
calculated using the method described by Pfaffl [40]. The
results for each target gene were normalized against the
results for chromosome alignment maintaining phospho-
protein 1 (CHAMP1), which exhibited the least variation
across the samples in a comparison of four house-keeping
genes (data not shown). CHAMP1 was previously identi-
fied as a constitutively and moderately expressed gene in
resting and activated monocytes [41].
Statistical analyses
Statistical analysis of ELISA data was performed using a
General Linear Model (GLM). The ratio of cytokine level
in the presence of LPS divided by cytokine level in
medium alone (fold increase) data were analysed using a
general linear model fitting cell type, animal and control
values as fixed effects. The control values were included
as covariates in order to increase the sensitivity of the
model. Post-hoc pairwise comparisons between cell
types were then made using Fisher tests. A similar GLM
analysis was conducted to compare cytokine levels in
the presence of medium alone across the three myeloid
populations, fitting cell type and animal in the model.
Differences in the expression of cell surface markers
were measured using One-Way ANOVA, whilst the vari-
ation in the mRNA levels of monocyte subset markers
measured by RT-qPCR was examined by paired t-test
analysis. All analyses were carried out within the Minitab
version 17 statistical package, with p < 0.05 considered
significant.
Results
Ruminant blood contains cell populations with
differential expression of CD14 and CD16
In order to identify myeloid cell populations in the periph-
eral blood of cattle, expression of CD14 and CD16 was
analysed on PBMC (n= 6). After dead cell and doublet dis-
crimination (Figure 1A and B), a number of CD16 positive
sub-populations with different fluorescence intensities and
complexity were evident (Figures 1F, 2A); whereas the ex-
pression of CD14 was more uniform with a major popula-
tion observed (Figures 1G, 2B). In order to further define the
nature of the CD14+ and CD16+ populations, PBMC were
double-labelled with anti-CD14 and anti-CD16 conjugated
antibodies, a method commonly used to identify monocyte
subsets in human blood [2,7,9,42]. Although considerable
variation in the staining patterns was observed across the
six cattle studied (Figure 2C), there was evidence for the
presence of a number of sub-populations of cells
with differential CD14 and CD16 expression. Within the
CD14 negative population there were cells with varying
levels of CD16 expression. We demonstrated that CD14−
C
D
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CD16
A
CD16
B
CD14
C
Q3 Q4
Q1 Q2
Figure 2 Expression of CD14 and CD16 defines subpopulations of cells in bovine peripheral blood with differential expression. The
expression of CD16 and CD14 was determined by flow cytometry in freshly isolated bovine PBMC. Live, single cells gated as in Figure 1, were
analysed by staining for CD16 (A) or CD14 (B). To further characterise these populations, live single cells were then assessed for expression of
CD16 and CD14 by double staining (C). Variable CD16 expression was observed. As shown in Figure 1 cells with CD16 fluorescence <400 were
negative for expression. Cells with a CD16 fluorescence between 800 and 10 000 were NKp46+ NK cells (panel Q3). Cells with CD16 fluorescence
above 10 000 (panel Q4) were identified as a discrete population of CD172a+ NKp46− CD16+CD14− cells (CD14−CD16++). CD14+ cells had
fluorescence intensity >300 and expressed differential levels of CD16. Two CD14+ populations were defined by a diagonal gate (panels Q1 and
Q2 [8]). Data shown are for one representative animal (A, B) and for six individual animals (C).
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panel Q3) were NK cells as these expressed NKp46
(Figure 1I) and were negative for CD172a (Figure 1J). Conse-
quently, these cells were excluded from further analysis. A
distinct population of cells also negative for CD14 and
with a CD16 MFI of greater than 10 000 (CD14−CD16++;
Figure 2C, panel Q4) was evident at relatively low propor-
tion (0.9 ± 0.5%).
A major population of cells expressing CD14 was present
at a relatively high proportion in PBMC (Figures 1G, 2B).
Within the CD14+ population, cells with variable levels of
CD16 were evident (Figure 2C, panels Q1 and Q2) similar
to that previously reported by Ziegler-Heitbrock and Hofer
[8] amongst others. Using the gating strategy suggested by
these authors to be the most appropriate for monocyte
populations, we demonstrated that the majority of theCD14+ cells expressed low levels of CD16 (16.2 ± 6.6% of
the total PBMC; average CD16 MFI 366 ± 99; Figure 2C,
panel Q1). A second population within the CD14+ cells
which expressed higher levels of CD16 (average CD16 MFI
4039 ± 607; Figure 2C, panel Q2) was evident as a smaller
and variable proportion in all animals studied (1.2 ± 0.4%).
The cell populations gated based on their expression of
CD14 and CD16 (Figure 2C, panels Q1, Q2, Q4) were then
assessed for size (FSC) and granularity (SSC) (Figure 3A-E).
Whilst the populations overlapped in terms of their FSC
and SSC, it was clear that the CD14−CD16++ population
(Figure 2C, panel Q4, Figure 3A, C, D highlighted in red)
was significantly less granular than either the CD14+CD16+
population (Figure 2C, panel Q2, Figure 3B, C, D
highlighted in blue) or the major CD14+CD16low/- popula-
tion (Figure 2C, panel Q1, Figure 3B, C, D highlighted in
BA C
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Figure 3 Size and granularity of bovine myeloid sub-populations. Live single PBMC were gated as shown in Figure 2C and each highlighted
in different colours for identification in side and forward scatter plots. The size and granularity of the populations was determined by their
characteristic side and forward scatter plots: in red, CD14−CD16++ (A); in orange, CD14+CD16low/- and, superimposed, the CD14+CD16+ population
in blue (B). Combining the plots (C) showed the difference of size and granularity of these cells. Data shown are for one representative animal out
of six. (D, E) Box and whiskers plots for the arithmetic mean SSC-H (D) and FSC-H (E) for each myeloid subset (n = 6) are presented as the mean
values ± SE, showing the difference in size and granularity of the populations. ** denotes significant difference (p < 0.001).
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size (FSC) of the CD14+CD16+ population was significantly
greater than either of the other two populations (p < 0.001;
Figure 3E).
Based on these data, we hypothesised that the
CD14−CD16++, CD14+CD16+ and CD14+CD16low/-
populations could have similar phenotypic and functional
characteristics to the human monocyte populations re-
ported widely in the literature: namely classical, intermedi-
ate and non-classical monocyte populations [2]. These
cells have not been extensively characterised in ruminants
and consequently we focused our investigations on these
three populations.Cell surface expression characteristics of CD14+CD16low/-,
CD14+CD16+ and CD14−CD16++ populations
Three-colour flow cytometry was performed to investi-
gate cell surface expression of a number of molecules in
the CD14−CD16++ (Figure 2C, panel Q4, Figure 4 (red));
CD14+CD16+ (Figure 2C, panel Q2, Figure 3 (blue)) and
CD14+CD16low/- (Figure 2C, panel Q1, Figure 4 (orange)).
Live, single cells were gated according to the expression of
CD14/CD16 (Figure 2C) and the expression of a panel of
molecules associated with specific cell lineages (lymphoid
and myeloid) and specific functions (antigen presentation
and co-stimulation) was assessed (Figure 4, Table 3).
Representative flow cytometry histograms are shown in
PBMC
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Figure 4 Phenotypic profiles of bovine myeloid cell sub-populations. Live gated PBMC were assessed for expression of CD16 and CD14
and a panel of molecules associated with antigen presentation, co-stimulation or specific cell lineages (see Table 1) by 3 colour flow cytometry. PBMC
were stained with primary mAb to the specific molecules indicated and then with an isotype-specific PE conjugated secondary, followed by
CD16 and CD14 conjugated to FITC or Alexa Fluor 647 respectively. Live, single PBMC were gated based on the expression of CD16 and CD14
as detailed in Figures 1 and 2C. Histograms show the levels of expression of selected markers in the cell populations studied, CD14−CD16++ (red),
CD14+CD16+ (blue) and CD14+CD16low/- (orange) compared to PBMC (black). Data shown are for one representative animal of four animals.
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Table 3 Phenotyping of CD14−CD16++, CD14+CD16+ and CD14+ CD16low/- cell populations
Cell marker CD14− CD16++
average MFI (SE)
CD14+ CD16+
average MFI (SE)
CD14+ CD16low/-
average MFI (SE)
CD1b 129 (28)a 113 (12) 54 (7)b Antigen presentation
Co-stimulatory molecules
CD80 2349 (378) 1590 (119) 1889 (66) Antigen presentation
Co-stimulatory molecules
CD86 1226 (172)a 2941 (291) 2403 (403)b Antigen presentation
Co-stimulatory molecules
CD40 9166 (1548) 7896 (1224) 6839 (967) Antigen presentation
Co-stimulatory molecules
MHC DR 46 014 (12 130) 63 800 (13650) 32 720 (9057) Antigen presentation
Co-stimulatory molecules
CD11b 20 755 (4334)a 32 631 (5299) 47 893 (9406)b Antigen presentation
Co-stimulatory molecules
CD11c 7575 (3295) 12 828 (4748) 21 093 (11339) Antigen presentation
Co-stimulatory molecules
CD3 <10a 43 (11)b 36 (8)b Lymphoid cell markers
CD4 <10 <10 <10 Lymphoid cell markers
CD8α <10 28 (3) 14 (4) Lymphoid cell markers
CD8β <10 10 (5) <10 Lymphoid cell markers
CD21 618 (140)A 247 (23)B 136 (18)B Lymphoid cell markers
NKp46 38 (16) 34 (3) 17 (2) Lymphoid cell markers
CD26 147 (37) 151 (22) 110 (21) Lymphoid cell markers
CD172a 96 077 (31018) 100 076 (31620) 89 046 (28726) Myeloid cell markers
CD206 649 (260) 1533 (389)a 191 (32)b Myeloid cell markers
TLR2 92 (25) 299 (41) 261 (96) Myeloid cell markers
CD163 409 (68)A 1273 (58)B 1898 (222)C Myeloid cell markers
CD16 18 344 (1448)A 4039 (607)B 366 (99)C Myeloid cell markers
CD14 20 (16)A 978 (78)B 1748 (337)B Myeloid cell markers
Three colour flow cytometry was carried out on PBMC stained with selected mAb (details in Table 1) as primary antibodies and stained with an isotype-specific
R:PE conjugated secondary mAb, followed by directly conjugated mAbs CD16 and CD14. Following live/dead and singlets gating, PBMC were then gated based
on the expression of CD16 and CD14 as CD14-CD16++, CD14+CD16+ and CD14+ CD16low/- as shown in Figure 2 and expression of the markers was then analysed.
Geometric mean fluorescence intensity (MFI), corrected with the MFI of its corresponding FMO, for each of the molecules is shown in the table as an arithmetic
mean and standard error -SE (n = 4). Different letters denote significant difference in marker expression levels (MFI) between the three myeloid populations
(p < 0.05 (lower case) and p < 0.001 (upper case)).
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six individuals reported in Table 3. There were no sig-
nificant differences between the three populations in
the expression of CD172a, CD11c, CD40, MHCII-DR
and CD80 which were uniformly high, whereas CD3,
CD4, CD8α, CD8β, CD26 and NKp46 were consistently
negative compared to FMO controls.
For a number of molecules assessed, there were sig-
nificant differences between the populations (Table 3);
notably between the CD14+CD16low/- (Figure 4 (orange))
and the CD14−CD16++ (Figure 4 (red)) populations. Sig-
nificantly higher expression of CD1b was observed on the
CD14−CD16++ cells compared with the CD14+CD16low/-
cells (p = 0.039). For CD86 and CD11b significant
differences between the CD14+CD16low/- cells and the
CD14−CD16++ cells were also observed (p = 0.009 and 0.04
respectively). Although the majority of the CD14−CD16++cells were negative for CD21 (70 ± 13.2%), a proportion of
cells (29.9 ± 13.4%) exhibited a broad range of CD21
expression, albeit lower than the expression observed on B
cells in PBMC (Figure 4 (compare red with grey histo-
grams)). The overall MFI (618 ± 140) was significantly
higher than that for CD21 on both CD14+ populations
(p = 0.001). All three myeloid cell populations expressed
CD206, with staining patterns that indicated that vary-
ing proportions of two subsets, one CD206 positive and
one CD206 negative, may be present in each popula-
tion. In particular the majority of CD14+CD16+ cells
expressed CD206 at a significantly higher level com-
pared to the CD14+CD16low/- population (p = 0.002).
Expression of CD163 was significantly different across
the three populations with the lowest expression observed
on the CD14−CD16++ population (p < 0.001, when com-
pared to each CD14+ population). A trend towards lower
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observed (p = 0.091).Cytokine levels secreted by CD14+CD16low/-, CD14+CD16+
and CD14−CD16++ populations in the presence and
absence of LPS stimulation
To further investigate the differences of these myeloid
cell populations and assess their functional characteris-
tics, the three cell subpopulations identified in Figure 2C
(CD14−CD16++; CD14+CD16+ and CD14+CD16low/-)
were purified from PBMC of six animals. The purity and
the number of cells obtained were determined after sort-
ing (Table 4). The cytokine expression profile of each
population was assessed 18 h following stimulation
with LPS and compared to that of unstimulated cells
(Figure 5A-E). Although considerable variation in cytokine
levels was found between animals, there were significant
differences between the three myeloid subsets in terms of
the fold-change in response to LPS compared to the
controls for IL-1β (p < 0.001), IL-10 (p = 0.022) and
IL-12 (p = 0.018) (Figure 5A, D and E). Greater vari-
ation between animals in the constitutive levels of
IL-1β was observed in the two CD14+ populations
whereas the CD14−CD16++ cells consistently had
negligible levels of this cytokine (Figure 5A), which
were significantly lower than that produced constitu-
tively by either of the CD14+ populations (p = 0.001).
However, the CD14−CD16++ cells did respond to LPS
by secreting significantly more IL-1β compared to
the medium only controls (p < 0.001). No significant
difference between the three cell populations was
found in the production of TNF-α or IL-6 (Figure 5B
and C).
As observed for IL-1β, the CD14−CD16++ cells se-
creted significantly lower constitutive levels of IL-10
compared to the other two myeloid subsets which
showed greater variation between animals following LPS
stimulation (p = 0.037, Figure 5D). Low levels of IL-12Table 4 Myeloid cell purification
Animal ID CD14−CD16++ CD14+CD16+ CD14+CD16low/-
201243 400 000 1 100 000 1 100 000
601240 350 000 2 400 000 2 800 000
501246 500 000 1 800 000 3 500 000
301244 380 000 1 200 000 3 000 000
301237 550 000 1 650 000 3 500 000
101249 650 000 730 000 1 500 000
Example of Purity 96.5% 88.5% 90.6%
Numbers of cells collected in each of the cell sorts for cytokine response to
LPS stimulations of myeloid populations. Purities were consistently above 85%;
a representative example of the purities obtained is shown.were secreted by all 3 myeloid subpopulations. However
the CD14−CD16++ population exhibited a significantly
greater fold-change in response to LPS compared to
the controls than the major CD14+CD16low/- popula-
tion (p = 0.018, Figure 5E).
CD14−CD16++ cells induce higher allogeneic MLR than
either of the CD14+ populations
To further investigate the nature of the CD14−CD16++,
CD14+CD16+ and CD14+CD16low/- cell populations,
their capacity to induce lymphocyte proliferation was
assessed in an allogeneic MLR (Figure 6). At the highest
responder:stimulator ratio (10:1), the CD14−CD16++
population showed a significantly greater capacity to
induce proliferation when compared to the CD14+CD16low/-
cells (p = 0.029). A more pronounced difference was ob-
served when the ratio of responders to stimulators was
100:1, where the proliferation induced by the CD14
−CD16++ cells was significantly higher than that induced
by either of the CD14+ populations (p < 0.001).
Since few significant differences were observed
across a number of parameters (antigen presentation,
cytokine secretion, cell surface phenotype) between the
CD14+CD16low/- cells and the CD16+CD14+cells, add-
itional analyses were focused on the comparison of the
total CD14+ population to the CD14−CD16++ cells, as
described below.
Gene expression levels
To assess expression of key molecules reported to be
associated with monocyte populations we measured
expression of a panel of genes in purified monocyte pop-
ulations from four animals by RT-qPCR. This analysis
confirmed that the receptor for colony stimulating factor
1 (CSF1R; CD115) was expressed at similar levels in
both CD14+ and CD14−CD16++ samples (Figure 7),
although there was more animal to animal variation
within the CD14−CD16++ samples. CD115 was expressed
by both CD14+CD16low/- and CD14+CD16+ populations,
but not by NK cells (results not shown). CD14
mRNA levels were significantly higher, on average 8.2
fold (p = 0.001), in CD14+ cells and conversely
CD16A (FCGR3A) levels were significantly higher, on
average 14.1 fold (p = 0.027), in CD14−CD16++ cells.
Again there was considerable variation in the expression
of CD16A in the CD14−CD16++ cells (Figure 7). Further
analysis of genes known to be differentially expressed in
human and murine monocyte subsets revealed that
CX3CR1 was expressed at significantly higher levels in
CD14−CD16++ cells, with the expression being on average
4.9 fold higher than in CD14+ cells (p = 0.012). In contrast,
another chemokine receptor, CCR2, was expressed at sig-
nificantly higher levels, on average 5.3 fold, in CD14+ cells
than CD14−CD16++ cells (p = 0.004). The expression of
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Figure 5 LPS stimulation of distinct myeloid cell populations induces differential cytokine secretion profiles. Cells were purified by using
gating strategy shown in Figure 2C and stimulated for 18 h with LPS (black bars) or medium alone (grey bars). The levels IL-1b (A), TNF-a (B), IL-6
(C), IL-10 (D) and IL-12 (E) secreted into culture supernatants were measured by ELISA. The data is expressed as the concentration of cytokine
in picograms (pg) or biological activity (biological units (BU)) secreted by 106 cells. Different letters denote statistical significance between
the different cell populations: capital letters represent significant difference of the fold increase induced by stimulation (stimulated value divided by
un-stimulated control), while lowercase denotes significance in the comparison of un-stimulated values. Results are shown as the mean values with
error bars indicating ± SE of the sorted populations from six animals.
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in CD14+ cells, but not in CD14−CD16++ cells (data
not shown). Therefore, the phenotype of the bovine
monocyte populations are: CD14+CD16+/−CD163+CCR2+
and CD14−CD16++CX3CR1+.CD14−CD16++ cells have a significantly higher endocytic
capacity compared to CD14+ cells
To assess the capacity for antigen uptake by the CD14+
and CD14−CD16++ cell populations, PBMC from four
animals were incubated with either Dextran (DX), a
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Figure 6 Distinct myeloid cell populations induce allogeneic mixed leukocyte reactions of differing intensity. Three cell populations
(CD14−CD16++, CD14+CD16+, CD14+CD16low/-) were purified as shown in Figure 2C, irradiated and cultured at the indicated cell ratios with
responder PBMC (105 per well) for 5 days. Proliferation was measured by the incorporation of methyl-3H thymidine ([3H]TdR; 0.5 μCi per well) for
the final 18 h of culture. Data are presented as the corrected counts per minute (ccpm) averaged over 3 min. Error bars denote ± SE of the
technical replicates and letters represent statistical significance between proliferation induced by each cell population for each responder:stimulator
ratio for p < 0.05. One representative experiment of three is shown.
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CD206) by macropinocytosis [43] or Ovalbumin (OVA)
a protein taken up by clathrin-coated pits [44], both
fluorescently labelled with TexasRed (TR). The cell pop-
ulations were then identified within PBMC as CD14+ or
CD14−CD16++ after incubation with CD14 and CD16
mAbs. Low level internalisation was observed when cells
were incubated on ice for both TR-OVA (Figure 8A) and
TR-DX (Figure 8C); while significantly higher levels of
uptake were observed after incubation at 37 °C. Com-
paring uptake between the cell populations revealed
that the CD14−CD16++ cells internalised significantly
higher levels of TR-OVA when compared to the CD14+
cells (p = 0.03, Figure 8B).CD115 CD14 C
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Figure 7 Summary of the RT-qPCR analysis of the transcriptional prof
(FCGR3A), CCR2 and CX3CR1 mRNA fold differences detected in CD14+ (bla
fold difference compared to the sample with the lowest expression for eac
biological replicates. * denotes that the variation in expression was statisticBoth cell types were equally able to endocytose TR-DX
and although the CD14−CD16++ cells showed a trend
towards higher internalisation, when the TR MFI was
compared to that of the CD14+ cells (Figure 8D) this
difference did not reach statistical significance.
Distinct populations of myeloid cells based on differential
expression of CD14 and CD16 are also evident in sheep
The expression of CD14 and CD16 by ovine PBMC was
investigated in eight animals and compared to that of
bovine peripheral blood. As in cattle, single staining with
CD14 revealed one distinct population. However, the
overall percentage of cells expressing CD14 in ovine per-
ipheral blood was significantly lower when compared toD16A CX3CR1 CCR2
*
*
*
ile of monocyte subsets. Arithmetic mean of CD115, CD14, CD16A
ck bars) and CD16++ (grey bars) cells. The results are expressed as the
h gene. Error bars illustrate the standard deviation of four animals/
ally significantly different by t test (p < 0.05).
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Figure 8 Differential endocytosis of OVA and Dextran by subpopulations of myeloid cells. PBMC were isolated and incubated for 30 min
with 100 μg/mL of TexasRed-OVA (A, B) or TexasRed-Dextran (C, D) at 37 °C or on ice (to assess background uptake). The cells were subsequently
washed and stained with conjugated CD14 and CD16 antibodies and analysed by flow cytometry. Live, single cells were gated as in Figure 1 and
the MFI was calculated for the CD14−CD16++ and CD14+ gated populations (A, C). The results shown (B, D) are mean values with error bars
showing ± SE for four animals and represent the TexasRed MFI at 37 °C minus MFI on ice (4 °C).
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CD14 (Figure 9A). On the other hand, ovine blood con-
tained a comparable number of cells expressing CD16
(10.6 ± 5.1% of the total PBMC Figure 9B) to bovineblood. Within the CD14− fraction, CD16 was expressed
at a moderate level by the majority of cells (Figure 9C)
as previously described by others [28]. Very few CD14
−CD16++ cells were evident in ovine blood (0.6 ± 0.4% of
A B
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Figure 9 Subpopulations of myeloid cells with differential expression of CD14 and CD16 are present in ovine peripheral blood. The
expression of CD16 and CD14 was determined by single and two colour flow cytometry in freshly isolated ovine PBMC. Live, single cells gated as
in Figure 1 were further analysed for the expression of CD14 (A), CD16 (B) or were double stained with mAbs to CD16 and CD14 (C). Distinct
populations of cells were identified (C): CD14+CD16low/+, CD14−CD16++ and CD14−CD16+. Data shown are for one representative animal out
of eight.
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single CD14+ population (4.1 ± 0.9%) was discernible
with variable CD16 expression (CD16 MFI of 50 ± 5).
These low percentages precluded detailed investigation
of the phenotype and function of these different myeloid
populations in ovine peripheral blood.
Discussion
In this study we focused our investigations on the identi-
fication of monocyte subsets present in the peripheral
blood of cattle and sheep using two markers commonly
used to identify monocyte populations in human, namely
CD14 and CD16. In agreement with previous reports in
ruminants [28,29,45-47], single staining with mAbs spe-
cific for these molecules revealed one distinct population
based on levels of CD14 expression, whereas CD16+
cells displayed a range of expression levels. We have
shown that two clearly distinct CD172a+ cell populations
are present in bovine PBMC consisting of a major subset
of CD14+CD16low/- cells and a minor population of
CD14−CD16++ cells (88.1 ± 2.9%, and 5 ± 1.7% respect-
ively of CD172a+ cells). These can be distinguished from
NK cells by their lack of NKp46 expression and higher
CD16 expression. As in humans [8] there was also
present a more diffuse minor population (6.8 ± 2.0% of
CD172a+ cells) expressing a spectrum of CD14 and
CD16 levels in between those expressed by the more dis-
tinct monocyte subsets. In this regard, our data essen-
tially agree with that recently published by Hussen et al.
[31]. Although sheep are a closely related species, diver-
ging from cattle around 31 million years ago [48], there
were fewer circulating ovine monocytes and these exhib-
ited very different CD14 and CD16 staining patterns
from bovine monocytes. A single major CD14+CD16+
population was discerned with few CD14−CD16++ cells.It is unlikely that these differences were simply related
to different antibody affinities for ovine CD14 or CD16
as similar results have been obtained with mAb specific
for ovine CD14 (unpublished observations). Further-
more, ovine NK cells had similar levels of CD16 expres-
sion to bovine NK cells. It is possible that these
differences in monocyte subsets in the circulation are not
absolute, but reflective of differences in the steady state
migration to and from the blood, as well as proliferative
capacity and cell death rates of bovine and ovine mono-
cytes. However these differences warrant further investiga-
tion as they may, at least partly, explain different responses
of cattle and sheep to a range of pathogens.
The three bovine monocyte populations expressed
CD115, confirming their monocyte lineage and providing
further evidence that CD115 is the canonical conserved
marker of monocytes in vertebrate species. Although
some progress has been made on the generation of anti-
CD115 mAb for species other than humans and mice, in-
cluding chickens and pigs [49,50], so far no anti-CD115
mAb for ruminants or other species has been reported to
enable confirmation of the level of expression of CD115 at
the cell surface. The CD172a+CD14−CD16++ population
was the smallest in size, the least granular and, expressed
little or no CD14 and CD163 and relatively low levels of
CCR2 and CD11b, but was shown to express high levels
of CX3CR1. These cells thus resemble the human non-
classical population of monocytes [8] and the mouse
Ly6Clo monocyte population [51]. The CD14+ population,
on the other hand, expressed the highest levels of CD14,
the lowest levels of CD16, over four times the level of
CD163 expressed by the CD14−CD16++ cells (Table 3),
higher levels of CCR2 and lower levels of CX3CR1. This
major monocyte population thus has a similar phenotype
to the human classical population [52], mouse Ly6Chi
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The differential expression of the chemokine receptors in-
dicates that the two monocyte populations are likely to
migrate differently from the blood into the tissues in re-
sponse to inflammatory signals as well as under steady-
state conditions [5,10]. In contrast to human and mouse
monocytes, or indeed the previous report on bovine
monocytes [31], we were able to show that bovine classical
CD14+ monocytes were similar in size to the non-classical
population. The reason for the latter discrepancy is un-
clear, although porcine monocytes have been reported to
increase in size following differentiation in the presence of
CSF1 [18]. Instead, the intermediate CD14+CD16+ popu-
lation consisted of the largest cells which is in contrast to
Hussen et al. [31] which may reflect our different gating
strategies and exclusion of NK cells from our analysis.
The current nomenclature for human blood mono-
cytes, which segregates them into three subsets [7,11],
has been recognised to be subjective as different anti-
body clones and gating strategies have been used, and
consequently the populations studied in different reports
may also be different [8]. These studies have generated
some conflicting data, with some authors suggesting that
the classical and intermediate monocytes are clustered
separately from the non-classical monocytes [53], whilst
others state that it is actually the intermediate and the
non-classical which are more closely related [2]. Thus,
as described by Ziegler-Heitbrock and Hofer [8], gating
strategies for monocytes are essential particularly when
studying the intermediate monocyte population. Given
this, we ensured our gating strategy was consistent
across different animals and took account of threshold
for CD14 and CD16 negative populations, as well as the
intermediate CD16 levels expressed by some monocytes
and NK cells. This enabled us to clearly distinguish between
the major classical monocyte CD14+CD16low/- subset and
the non-classical CD14−CD16++ subset. In addition, we de-
fined the CD14−CD16++ monocyte population on the basis
of lack of CD14 expression and distinctly higher expression
of CD16 than the NK cell population. This is in contrast to
the previous report which used a different gating strategy
and defined CD14+CD16+ cells as the bovine non-classical
monocyte subset [31].
Even though the distinction of the intermediate popu-
lation from the CD14+CD16low/- and the CD14+CD16+
cells was less clear, we applied a consistent gate across
all samples and used this strategy together with cell sort-
ing to purify the three populations for functional ana-
lysis. The CD14+CD16+ population mainly expressed
levels of cell surface molecules that varied between the
levels in the other two monocyte populations, and are
thus similar to the intermediate monocyte phenotype
described in humans and mice [2,54]. This would be in
line with the view that these cells are maturing fromCD14+CD16low/- monocytes to become CD14−CD16++
monocytes [2]. In addition, all monocyte subsets were
negative for lymphoid markers, with one exception (see
below).
In order to explore the nature of the three CD115
+CD172a+ monocyte populations further, three colour
flow cytometry was carried out with selected molecules.
The three populations were positive for most of the
APC markers, co-stimulatory molecules and myeloid
markers. In terms of antigen presenting function all
three populations expressed similar levels of CD40,
CD80 and bovine MHC class II DR, although the levels
on intermediate CD14+CD16+ cells showed a trend to-
wards higher expression. This would be in agreement
with the earlier report on monocyte populations in cattle
[31] and also with human and porcine intermediate
monocytes [2,18]. The CD14+CD16low/- population
expressed higher levels of CD86 than the CD14−CD16++
population whereas the CD14−CD16++ expressed higher
levels of CD1b. CD1 is a multi-gene family in cattle and
different CD1 molecules are expressed on B cells and
DC, although B cells do not always express the proteins
on the cell surface [55]. This molecule is involved in
presentation of lipid antigens and is important in Myco-
bacterial infections [56]. The antibody used in our study
has been shown to recognise CD1b3 which is expressed
on cattle afferent lymph dendritic cells (ALDC) and im-
mature DC derived from monocytes [55]. It is likely that
the relatively low levels of CD14−CD16++ cells in periph-
eral blood together with the low, though significant, cell
surface expression of CD1b3, has precluded its detection
previously in PBMC. Intriguingly a subset of CD14
−CD16++ were also positive for CD21, a marker typically
present on B cells, which has however also been re-
ported to be expressed by a subpopulation of bovine
ALDC [57] and in human follicular dendritic cells [58].
Further, both the intermediate and CD14−CD16++ had
subsets expressing CD206 or the mannose receptor, a
C-type lectin typically present in macrophages and im-
mature dendritic cells [59]. This receptor is active in
endocytosis and phagocytosis and recognises specific
mannosylated protein antigens found on the surface of
pathogens, playing a key role in both the innate and
adaptive immune systems [60]. However the higher
expression of CD206 on CD14−CD16++ monocytes did
not result in significantly higher uptake of dextran,
although they did take up higher levels of ovalbumin, a
process which can also be dependent on CD206 [61].
Thus it is possible that the same subset of the CD14
−CD16++ monocytes express CD172a, CD1b3, CD21
and CD206. If so, these cells would have a similar
phenotype to the subpopulation of bovine CD172a
+CD1b3+CD21+CD206+ ALDC which have greater cap-
acity to take up both dextran and ovalbumin than other
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ALDC also phagocytose pathogens such as M. bovis but
are less effective at antigen presentation to T cells [59].
Further multi-colour cytometric analysis is required to
confirm whether there is a subpopulation of CD172a
+CD14−CD16++CD1b3+ monocytes which also express
CD21 and CD206. Certainly, further monocyte subpop-
ulations that are not conventionally defined by CD14
and CD16 have been reported in humans, including Tie
+ monocytes that overlap with the intermediate mono-
cyte subset and 6-sulpho LacNAc+ (SLAN; a carbohy-
drate modification of P-selectin glycoprotein ligand 1)
monocytes that appear to be a subset of CD14−CD16++
monocytes [11].
Although data are now beginning to appear about
monocyte subsets in other mammalian species [52], in-
formation is very limited in species within the artiodac-
tyla clade, partly due to the paucity of antibodies against
specific particular markers, and can have conflicting
conclusions. Porcine monocytes for example, differ in
expression of surface CD14 and the scavenger receptor
for the hemoglobin-haptoglobin complex, CD163. In
early reports the porcine population identified as CD163
+CD14−, was related to the human CD14+CD16+ popu-
lation due to the functional and phenotypic characteris-
tics of these cells [62,63]. Recently, this comparison has
been challenged and comparing differential gene expres-
sion data of monocyte populations from human, mouse
and pig, no obvious equivalent to human non-classical
monocytes could be found. Despite this, a relationship
between porcine CD163lowCD14++ cells and the human
classical CD14++ population was established [18]. In
contrast to pigs, but similar to humans [64,65], CD163
was weakly positive in the bovine CD14−CD16++ cells
compared to the higher level present in the bovine
CD14+CD16low/- monocytes and this agrees with the
previous report [31]. In horses, limited analysis suggests
that the majority of CD14+ monocytes are CD16−, and a
minority are CD16+, possibly corresponding to the clas-
sical and intermediate monocytes of other species [66] but
so far there has been no further phenotyping or functional
analysis of equine monocyte subsets.
To investigate the three monocyte populations further,
and to establish if these cells differ in function, we sepa-
rated the populations based on their differential expres-
sion of CD14 and CD16 using fluorescence-activated
cell sorting. A previous report had suggested that CD14
+CD16+ monocytes did not up-regulate mRNA for
CXCL8 or IL-1β in response to LPS, suggesting that the
cells they referred to as non-classical were not inflam-
matory [31]. In contrast, in our hands, all three popula-
tions responded to LPS by producing IL-1β protein
including the CD14−CD16++ cells, which had the lowest
constitutive levels of IL-1β. The contradictory resultsmay reflect differences in the gating strategies and selec-
tion methods, as we sorted the cell populations using
flow cytometry to high purity enabling exclusion of
CD16+ NK cells. Unfortunately considerable variation
between animals precluded any conclusions with respect
to the pro-inflammatory cytokines TNF-α and IL-6 and
warrants further investigation with a larger sample set as
well as other agonists.
Overall, it appears that the classical CD14+CD16low/-
and intermediate monocytes produce both constitutively
more IL-10 and the least IL-12, in comparison with the
CD14−CD16++. Secretion of IL-10 is a feature of human,
mouse and pig classical monocytes whereas non-
classical monocytes produce little or no IL-10 [2,8,67].
In contrast some reports suggest that non-classical
monocytes, in particular the human CD14−CD16+
+SLAN+ monocyte subset [68], have a propensity to pro-
duce IL-12 in response to stimulation [42]. Unfortunately
we were unable to obtain an anti-SLAN mAb which
cross-reacted with bovine cells (results not shown).
Finally, we investigated the capacity of all three popu-
lations to induce an allogeneic MLR using the three
populations as stimulators and PBMC as responders
from two animals with different homozygous MHC class
I haplotypes. The CD14−CD16++ monocytes had a sig-
nificantly higher capacity to induce proliferation in
PBMC than either of the CD14+ subsets. Nonetheless it
remains unclear what features of this population enable
it to induce an allogeneic response, as the majority of
antigen presenting and co-stimulatory molecules are not
expressed at higher levels in these cells compared to the
CD14+ subsets. Further phenotypic and functional work
on the CD14−CD16++ monocytes and potential subsets
within this classification may provide additional insights.
In summary, we have extended earlier findings [31],
with additional phenotypic and functional characterisa-
tion of bovine monocytes and added information on
ovine monocyte subsets. In many ways the major CD14+
population in cattle blood shares many features with
classical monocytes of other species. Although we care-
fully defined a consistent gating strategy, it is not clear
that the less distinct CD14+CD16+ cells are part of a
separate population but could represent the maturation
and differentiation of the major CD14+ monocytes into
CD14−CD16++ monocytes. This latter subset shares
many features with non-classical monocytes of other
species and also may contain further subset(s) which
share features more commonly associated with DC. The
presence and function of all three populations during in-
fections and other inflammatory diseases in cattle needs
to be explored further to determine what role they might
play in immunity, and whether their levels in blood
might be used as correlates of protection and pathogen-
esis in ruminants.
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